Epsins 1 and 2 promote NEMO linear ubiquitination via LUBAC to drive breast cancer development
Kai Song(Soochow University), Hong Chen(CTI BioPharma (Italy)), Alana L. Welm(Huntsman Cancer Institute), Hao Wu(Yanbian University of Science and Technology), Aiyun Wen, Kevin Camphausen(National Cancer Institute), Yibin Kang(Rutgers, The State University of New Jersey), Kui Cui(Boston Children's Hospital), Yong Wei(The Ohio State University), Diane R. Bielenberg(Boston Children's Hospital), Xiaofeng Cai(Oklahoma Medical Research Foundation), Uma Shankavaram(National Cancer Institute), Sudarshan Bhattacharjee(Boston Children's Hospital), Bo Zhu(Hebei Medical University), Beibei Wang(Hebei Medical University), Kun Zhang(Shanghai Jiao Tong University), Lili Yu(Boston Children's Hospital), Yang Lee(Mitchell Institute), Lijun Xia(Oklahoma Medical Research Foundation), Scott W. Wong(Oregon National Primate Research Center), Yunzhou Dong(WinnMed)
Cited by 37
Related Papers
Tumour exosome integrins determine organotropic metastasis
|Nature|2015|5.2k
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
|Nature Medicine|2012|3.7k
A multigenic program mediating breast cancer metastasis to bone
|Cancer Cell|2003|2.6k
Guidelines and definitions for research on epithelial–mesenchymal transition
|Nature Reviews Molecular Cell Biology|2020|2.3k
Pre-metastatic niches: organ-specific homes for metastases
|Nature reviews. Cancer|2017|1.9k